NAFLD

https://pubmed.ncbi.nlm.nih.gov/36131081/ NAFLD

Sci Rep. 2022 Sep 21;12(1):15739.
doi: 10.1038/s41598-022-20104-y.

Updated reference ranges for aminotransferase levels of Korean children and young adolescents based on the risk factors for metabolic syndrome

Young-Jun Seo 1, Young Suk Shim 2, Hae Sang Lee 3, Jin Soon Hwang 3
Affiliations expand
PMID: 36131081

PMCID: PMC9492680

DOI: 10.1038/s41598-022-20104-y
Free PMC article
Abstract

Published on: 
Sep-2022

https://pubmed.ncbi.nlm.nih.gov/35899561/ NAFLD

Turk J Pediatr. 2022;64(3):482-489.
doi: 10.24953/turkjped.2022.41.

Urinary C-peptide creatinine ratio is a significant indicator of non-alcoholic fatty liver disease in children with obesity

Hekma Saad Farghaly 1, Kotb Abbass Metwalley 1, Yasser Gamal 1, Ghada Mohamed Saied 2, Yasser Yasser 1
Affiliations expand
PMID: 35899561

DOI: 10.24953/turkjped.2022.41
Free article

Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is the commonest etiology of chronic hepatic problems in children with obesity. This study aimed to assess whether urinary C-peptide creatinine ratio (UCPCR) might be a potential indicator of NAFLD in obese children.

Published on: 
Jul-2022

https://pubmed.ncbi.nlm.nih.gov/34872045/ NAFLD

Clin Nutr. 2021 Nov 23;41(1):105-121.
doi: 10.1016/j.clnu.2021.11.016.Online ahead of print.

Τhe anthropometric and biochemical profile of pediatric non-alcoholic fatty liver disease: A systematic review and a meta-analysis

Andreas Vadarlis 1, Sofia Chantavaridou 2, Georgios Kalopitas 3, Dimitra Rafailia Bakaloudi 4, Evangelia Karanika 4, Eirini Tsekitsidi 4, Michail Chourdakis 5

Abstract

Published on: 
Nov-2021

https://pubmed.ncbi.nlm.nih.gov/38291699/ NAFLD

J Pediatr Gastroenterol Nutr. 2024 Jan;78(1):27-35.
doi: 10.1002/jpn3.12068. Epub 2023 Dec 29.

Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease

Laura Kalveram 1, Ulrich Baumann 2 3, Ruth De Bruyne 4, Laura Draijer 5, Wojciech Janczyk 6, Deirdre Kelly 7, Bart G Koot 5, Florence Lacaille 8, Sander Lefere 9, Hadar Moran Lev 10, Judith Lubrecht 11, Jake P Mann 7, Antonella Mosca 12, Sanjay Rajwal 13, Piotr Socha 6, Anita Vreugdenhil 11, Anna Alisi 14, Christian A Hudert 1; ESPGHAN Fatty Liver Special Interest Group

Abstract

Published on: 
Jan-2024

https://www.ncbi.nlm.nih.gov/pubmed/30337653 NAFLD

Int J Obes (Lond). 2018 Oct 18. doi: 10.1038/s41366-018-0227-6. [Epub ahead of print]
A low visceral fat proportion, independent of total body fat mass, protects obese adolescent girls against fatty liver and glucose dysregulation: a longitudinal study.
Umano GR1,2, Shabanova V3, Pierpont B1, Mata M1, Nouws J1, Tricò D4,5, Galderisi A1,6, Santoro N1, Caprio S7.

Abstract

BACKGROUND:
The relative proportion of visceral fat (VAT) to subcutaneous fat (SAT) has been described as a major determinant of insulin resistance (IR). Our study sought to evaluate the effect of body fat distribution on glucose metabolism and intrahepatic fat content over time in a multiethnic cohort of obese adolescents.

SUBJECTS/METHODS:

Published on: 
Oct-2018

https://www.ncbi.nlm.nih.gov/pubmed/28697852

Jaramillo JD1, Snyder E1, Farrales S2, Stevens M2, Wall JK2, Chao S2, Morton J1, Pratt JS2, Hammer L3, Shepard WE3, Bruzoni M4.

ABSTRACT

BACKGROUND:
Childhood obesity has become a serious public health problem in our country with a prevalence that is disproportionately higher among minority groups. Laparoscopic sleeve gastrectomy (LSG) is gaining attention as a safe bariatric alternative for severely obese adolescents.

STUDY DESIGN:
A retrospective study on morbidly obese adolescents that underwent LSG at our institution from 2009 to 2017. Primary outcomes were weight loss as measured by change in BMI and percent excess weight loss (%EWL) at 1 year after surgery, resolution of comorbidities and occurrence of complications.

Published on: 
Jun-2017

http://www.ncbi.nlm.nih.gov/pubmed/26469357

. NAFLD

Abdel-Razik A, Mousa N, Shabana W, Refaey M, ElMahdy Y, Elhelaly R, Elzehery R, Zalata K, Arafa M, Elbaz S, Hafez M, Awad M. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study. Eur J Gastroenterol Hepatol. 2016 Jan; 28(1):e1-9.

Abstract

BACKGROUND AND AIM:

Published on: 
Jan-2016

https://pubmed.ncbi.nlm.nih.gov/31810868/ NAFLD

Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):513-523.

Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model

Ming Ma 1, Qi Long 2, Fei Chen 2, Ting Zhang 2, Wenqiao Wang 2
PMID: 31810868

Abstract

Objective: Non-alcoholic fatty liver disease (NAFLD) refers to an accumulation of excess fat in liver due to causes other than alcohol use. The relationship between vitamin D (VD) and NAFLD has been previously studied. Therefore, we aimed to explore the mechanism involved active VD regulating the progression of NAFLD by inhibiting cell senescence and to provide a potential approach for further nutritional treatment of NAFLD.

Published on: 
Sep-2020

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: